Tylenol Pm Extra Strength Tablet, Film Coated
NDC Package 70264-028-01
Package Information
Tylenol Pm Extra Strength (acetaminophen) tablets is a medication used to treat mild to moderate pain (from headaches, menstrual periods, toothaches, backaches, osteoarthritis, or cold/flu aches and pains) and to reduce fever. This formulation utilizes a tablet, film coated delivery system. Marketed by R J General Corporation, this product is identified by NDC 70264-028 and is authorized under FDA application M013.
Identification & Billing
- RxCUI: 1092189 - acetaminophen 500 MG / diphenhydrAMINE HCl 25 MG Oral Tablet
- RxCUI: 1092189 - acetaminophen 500 MG / diphenhydramine hydrochloride 25 MG Oral Tablet
- RxCUI: 1092189 - APAP 500 MG / diphenhydramine hydrochloride 25 MG Oral Tablet
- RxCUI: 1092378 - Tylenol PM 500 MG / 25 MG Oral Tablet
- RxCUI: 1092378 - acetaminophen 500 MG / diphenhydramine hydrochloride 25 MG Oral Tablet [Tylenol PM]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70264 - R J General Corporation
- 70264-028 - Tylenol Pm Extra Strength
- 70264-028-01 - 50 POUCH in 1 BOX / 2 TABLET, FILM COATED in 1 POUCH
- 70264-028 - Tylenol Pm Extra Strength
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70264-028-01 identifies a specific commercial package of 50 pouch in 1 box / 2 tablet, film coated in 1 pouch of Tylenol Pm Extra Strength, a human over the counter drug labeled by R J General Corporation. This tablet, film coated is formulated for oral use and contains acetaminophen; diphenhydramine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by R J General Corporation on May 01, 2021. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This drug is used to treat mild to moderate pain (from headaches, menstrual periods, toothaches, backaches, osteoarthritis, or cold/flu aches and pains) and to reduce fever.
How is this R J General Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70264002801. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.